[1] Das M, Fox CF. Chemical cross-linking in biology. Annu Rev Biophys Bioeng. 1979;8:165-93. Review.

[2] Butler VF, Jr. The immunological assay of drugs. Pharmacol Rev. 1978; 29(2): 103-184.

[3] Kovalev IE, Polevaya OYu. Biochemical basis of immunity to low molecular weight chemical compounds. M: Nauka. 1985; 304 p.

[4] Han K-K, Richard C, Delacourte A. Chemical cross-links of proteins by using bifunctional reagents. Int J Biochem. 1984;16(2):129–45.

[5] Feeney RE. Chemical modification of proteins: comments and perspectives. Int J Pept Protein Res. 1987;29(2):145-61.

[6] Muller S. Peptide-carrier conjugation. Synthetic polypeptides as antigens. Amsterdam : Elsevier, 1988. 350 p.

[7] Sela M, Arnon R. Studies on the chemical basis of the antigenicity of proteins. 1. Antigenicity of polypeptidyl gelatins. Biochem J. 1960;75:91-102.

[8] Arnon R, Sela M. Studies on the chemical basis of the antigenicity of proteins. 2. Antigenic specificity of polytyrosyl gelatins. Biochem J. 1960;75:103-9.

[9] Sela M, Arnon R. A specific synthetic polypeptide antigen. Biochim Biophys Acta. 1960;40:382-4.

[10] Sela M. Antigenicity: some molecular aspects. Science. 1969;166(3911):1365-74.

[11] Arnon R. Immunity of viral and rickettsial disease. New York : Plenum press, 1972. 209 p.

[12] Schaaper WM, Lankhof H, Puijk WC, Meloen RH. Manipulation of antipeptide immune response by varying the coupling of the peptide with the carrier protein. Mol Immunol. 1989;26(1):81-5.

[13] Rhodes G, Houghten R, Taulane JP, Carson D, Vaughan J. The immune response to Epstein-Barr nuclear antigen: conformational and structural features of antibody binding to synthetic peptides. Mol Immunol. 1984;21(11):1047-54.

[14] Dyson HJ, Cross KJ, Houghten RA, Wilson IA, Wright PE, Lerner RA. The immunodominant site of a synthetic immunogen has a conformational preference in water for a type-II reverse turn. Nature. 1985 Dec 5-11;318(6045):480-3.

[15] Geysen HM, Barteling SJ, Meloen RH. Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein. Proc Natl Acad Sci U S A. 1985;82(1):178-82.

[16] Dyrberg T, Oldstone MB. Peptides as antigens. Importance of orientation. J Exp Med. 1986;164(4):1344-9.

[17] Marini S, Bannister J, Giardina B. A simple method for increasing hapten immunogenicity by a specific structural modification of the carrier. J Immunol Methods. 1989;120(1):57-63.

[18] Ponsati B, Giralt E, Andreu D. A synthetic strategy for simultaneous purification-conjugation of antigenic peptides. Anal Biochem. 1989;181(2):389-95.

[19] Pfaff E, Mussgay M, Böhm HO, Schulz GE, Schaller H. Antibodies against a preselected peptide recognize and neutralize foot and mouth disease virus. EMBO J. 1982;1(7):869-74.

[20] Walter G, Scheidtmann KH, Carbone A, Laudano AP, Doolittle RF. Antibodies specific for the carboxy- and amino-terminal regions of simian virus 40 large tumor antigen. Proc Natl Acad Sci U S A. 1980;77(9):5197-200.

[21] Juillerat MA, Barkas T, Tzartos SJ. Antigenic sites of the nicotinic acetylcholine receptor cannot be predicted from the hydrophilicity profile. FEBS Lett. 1984;168(1):143-8.

[22] Grebenshchikova OG, Andrianova LE, Prozorovskiy VN. Antipeptide antibodies to the porcine lactate dehydrogenase active center fragment. Immunologiia. 1989;4:28-31.

[23] Beachey EH, Tartar A, Seyer JM, Chedid L. Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein. Proc Natl Acad Sci U S A. 1984;81(7):2203-7.

[24] Streckert HJ, Brüssow H, Sure K, Werchau H. Antipeptide antibodies directed against the carboxy-terminal region of SV40 structural proteins VP2 and VP3. J Cell Biochem. 1986;31(4):277-87.

[25] Babinska A, Cierniewski CS, Koziolkiewicz W, Janecka A. Specificity of antisera obtained to substance P and its C-terminal hexapeptide. Int J Pept Protein Res. 1985;25(1):69-75.

[26] Pessino A, Gherzi R, Damiani G, Longhi R, Adezati L, Cordera R. Antipeptide antibodies toward the extracellular domain of insulin receptor beta-subunit. Biochem Biophys Res Commun. 1989;162(3):1236-43.

[27] Welling GW, Fries H. Choice of peptide and peptide length for the generation of antibodies reactive with the intact protein. FEBS Lett. 1985;182(1):81-4.

[28] Schutze MP, Leclerc C, Jolivet M, Audibert F, Chedid L. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J Immunol. 1985;135(4):2319-22.

[29] Altman A, Cardenas JM, Houghten RA, Dixon FJ, Theofilopoulos AN. Antibodies of predetermined specificity against chemically synthesized peptides of human interleukin 2. Proc Natl Acad Sci U S A. 1984;81(7):2176-80.

[30] Andreu D, de la Viña S, Andreu JM. Chemical synthesis of five tubulin antigenic sequences. Production and characterization of their corresponding anti-tubulin monospecific antibodies. Int J Pept Protein Res. 1988;31(6):555-66.

[31] Askelöf P, Rodmalm K, Abens J, Undén A, Bartfai T. Use of synthetic peptides to map antigenic sites of Bordetella pertussis toxin subunit S1. J Infect Dis. 1988;157(4):738-42.

[32] Petrov PV, Ivanov VT, Kozhin AT. Detection of antibodies against HIV-I and HIV-2 using a synthetic antigenic determinant. Immunologiia. 1990; 2: 12-5.

[33] Bowes JH, Cater CW. The interaction of aldehydes with collagen. Biochim Biophys Acta. 1968;168(2):341-52.

[34] Habeeb AJ, Hiramoto R. Reaction of proteins with glutaraldehyde. Arch Biochem Biophys. 1968;126(1):16-26.

[35] Tramezzani JH, Chiocchio S, Wassermann GF. A technique for light and electron microscopic identification of adrenalin- and noradrenalin-storing cells. J Histochem Cytochem. 1964;12:890-9.

[36] Wilson CO. Textbook of organic and pharmaceutical chemistry. Eds. C. O. Wilson, O. Giswold. Philadelphia i Lippincott Co, 1971: 155.

[37] Monsan P, Puzo G, Mazarguil H. Mechanism of glutaraldehyde-protein bond formation. Biochimie. 1975;57(11-12):1281-92.

[38] Peters K, Richards FM. Chemical cross-linking: reagents and problems in studies of membrane structure. Annu Rev Biochem. 1977;46:523-51.

[39] Drijfhout JW, Perdijk EW, Weijer WJ, Bloemhoff W. Controlled peptide-protein conjugation by means of 3-nitro-2-pyridinesulfenyl protection-activation. Int J Pept Protein Res. 1988;32(3):161-6.

[40] Jolivet M, Lise L, Gras-Masse H, Tartar A, Audibert F, Chedid L. Polyvalent synthetic vaccines: relationship between T epitopes and immunogenicity. Vaccine. 1990;8(1):35-40.

[41] Goodfriend TL, Levine L, Fasman GD. Antibodies to Bradykinin and Angiotensin: A Use of Carbodiimides in Immunology. Science. 1964;144(3624):1344–6.

[42] Oude Weernink PA, Rijksen G, Staal GE. Production of a specific antibody against pyruvate kinase type M2 using a synthetic peptide. FEBS Lett. 1988;236(2):391-5.

[43] Shapira M, Jibson M, Muller G, Arnon R. Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin. Proc Natl Acad Sci U S A. 1984;81(8):2461-5.

[44] Müller GM, Shapira M, Arnon R. Anti-influenza response achieved by immunization with a synthetic conjugate. Proc Natl Acad Sci U S A. 1982;79(2):569-73.

[45] Reichert CM, Carelli C, Jolivet M, Audibert F, Lefrancier P, Chedid L. Synthesis of conjugates containing N-acetylmuramyl-L-alanyl-D-isoglutaminyl (MDP). Their use as hapten-carrier systems. Mol Immunol. 1980;17(3):357-63.

[46] Atassi MZ, Kazim AL, Sakata S. High yield coupling of peptides to protein carriers. Biochim Biophys Acta. 1981;670(2):300-2.

[47] Shibnev VA, SharetskiÄ­ AN, Valiev RV, Khalikov ShKh. Various approaches to designing the functionally active determinants as illustrated by the influenza virus A(H3N2) hemagglutinin. Bioorg Khim. 1990;16(7):926-32.

[48] Carelli C, Ralamboranto L, Audibert F, Gaillard J, Briquelet N, Dray F, Fafeur V, Haour F, Chedid L. Immunological castration by a totally synthetic vaccine: modification of biological properties of LH-RH after conjugation to adjuvant-active muramyl peptide. Int J Immunopharmacol. 1985;7(2):215-24.

[49] Petrov PV, Khaitov PM, Liozner AL. et al. Induction of antibodies to influenza viruses synthetic peptide-polyelectrolyte complexes with specificity to constant of the molecule hemagglutinin. Immunologiia. 1986;5:24-7.

[50] Staros JV, Wright RW, Swingle DM. Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal Biochem. 1986;156(1):220-2.

[51] Briand JP, Muller S, Van Regenmortel MH. Synthetic peptides as antigens: pitfalls of conjugation methods. J Immunol Methods. 1985;78(1):59-69.

[52] Andreev SM, Sidorova MV, Rakova OA, Tsvetkov DE, Fonina LA. Synthesis of N-hydroxysuccinimide esters of carboxylic polymers and organic acids using N-trifluoroacethoxysuccinimide. Bioorg Khim. 1987; 13(5):696-700.

[53] Sakakibara S, Inukai N. The trifluoroacetate method of peptide synthesis. I. The synthesis and use of trifluoroacetate reagents. Bull Chem Soc Jpn. 1965;38(11):1979-84.

[54] Andreev SM, Meshcheryakova DB, Vafina MG, Az'muko AA, Sidorova MV, Khaitov RM. Analysis of the fine structure of the antigenic determinants of the transmembrane protein in the HIV coat with chemically modified synthetic peptides. Biomed Sci. 1991;2(3):271-8.

[55] Methods in immunology and immunochemistry. Eds. C. A. Williams, M. W. Chase. New York, London : Acad, press. 1967; 479 p.

[56] Tager HS. Coupling of peptides to albumin with difluorodinitrobenzene. Anal Biochem. 1976;71(2):367-75.

[57] Ratnam M, Lindstrom J. Structural features of the nicotinic acetylcholine receptor revealed by antibodies to synthetic peptides. Biochem Biophys Res Commun. 1984;122(3):1225-33.

[58] Aldwin L, Nitecki DE. A water-soluble, monitorable peptide and protein crosslinking agent. Anal Biochem. 1987;164(2):494-501.

[59] Kitagawa T, Shimozono T, Aikawa T, Yoshida T, Nishimura H. Preparation and characterization of hetero-bifunctional cross-linking reagents for protein modifications. Chem Pharm Bull. 1981;29(4):1130–5.

[60] Scott D, Nitecki DE, Kindler H, Goodman JW. Immunogenicity of biotinylated hapten-avidin complexes. Mol Immunol. 1984;21(11):1055-60.

[61] Hashimoto K, Loader JE, Kinsky SC. Iodoacetylated and biotinylated liposomes: effect of spacer length on sulfhydryl ligand binding and avidin precipitability. Biochim Biophys Acta. 1986;856(3):556-65.

[62] Nitecki DE, Aldwin L. High-technology route to virus vaccines. 11 Amer. Soc, Microbiol. Washington, 1985. 217 p.

[63] Aldwin L, Nitecki DE. Peptides, structure and function. Proc. of the 9th Amer. Peptide Symp. Toronto, 1985: 31-34.

[64] Herrera R, Petruzzelli L, Thomas N, Bramson HN, Kaiser ET, Rosen OM. An antipeptide antibody that specifically inhibits insulin receptor autophosphorylation and protein kinase activity. Proc Natl Acad Sci U S A. 1985;82(23):7899-903.

[65] Lerner RA, Green N, Alexander H, Liu FT, Sutcliffe JG, Shinnick TM. Chemically synthesized peptides predicted from the nucleotide sequence of the hepatitis B virus genome elicit antibodies reactive with the native envelope protein of Dane particles. Proc Natl Acad Sci U S A. 1981;78(6):3403-7.

[66] Liu FT, Zinnecker M, Hamaoka T, Katz DH. New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugates. Biochemistry. 1979;18(4):690-3.

[67] Kennedy RC, Henkel RD, Pauletti D, Allan JS, Lee TH, Essex M, Dreesman GR. Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science. 1986;231(4745):1556-9.

[68] Kitagawa T, Aikawa T. Enzyme coupled immunoassay of insulin using a novel coupling reagent. J Biochem. 1976;79(1):233-6.

[69] Iwai K, Fukuoka S, Fushiki T, Kido K, Sengoku Y, Semba T. Preparation of a verifiable peptide-protein immunogen: direction-controlled conjugation of a synthetic fragment of the monitor peptide with myoglobin and application for sequence analysis. Anal Biochem. 1988;171(2):277-82.

[70] Carlsson J, Drevin H, Axén R. Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem J. 1978;173(3):723-37.

[71] Myers DA, Murdoch WJ, Villemez CL. Protein-peptide conjugation by a two-phase reaction. Biochem J. 1985;227(1):343.

[72] Neurath AR, Strick N, Girard M. Hepatitis B virus surface antigen (HBsAg) as carrier for synthetic peptides having an attached hydrophobic tail. Mol Immunol. 1989;26(1):53-62.

[73] Pkhakadze OG, Kavun EM, Chechot VA. et al. Rabbit polyclonal antibodies recognizing site hemagglutinin B. pertussis, which is responsible for interaction with the CR-3 receptor. Abstr. VI Eng. Biochem. Congress. Kyiv, 1992; Part III:107.

[74] Peeters JM, Hazendonk TG, Beuvery EC, Tesser GI. Comparison of four bifunctional reagents for coupling peptides to proteins and the effect of the three moieties on the immunogenicity of the conjugates. J Immunol Methods. 1989;120(1):133-43.

[75] Bernatowicz MS, Matsueda GR. The N-hydroxysuccinimide ester of Boc-[S-(3-nitro-2-pyridinesulfenyl)]-cysteine: a heterobifunctional cross-linking agent. Biochem Biophys Res Commun. 1985;132(3):1046-50.

[76] Cuatrecasas P. Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads. J Biol Chem. 1970;245(12):3059-65.

[77] Segal DM, Hurwitz E. Dimers and trimers of immunoglobulin G covalently cross-linked with a bivalent affinity label. Biochemistry. 1976;15(24):5253-8.

[78] Higgins W, Miles EW. Affinity labeling of the pyridoxal phosphate binding site of the beta2 subunit of Escherichia coli tryptophan synthase. J Biol Chem. 1978;253(13):4648-52.

[79] Sayre LM, Larson DL, Takemori AE, Portoghese PS. Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different mu receptor subtypes in different tissues. J Med Chem. 1984;27(10):1325-35.

[80] Santi DV, Cunnion SO. Macromolecular affinity labeling agents. Reaction of N-bromoacetylisoleucyl transfer ribonucleic acid with isoleucyl transfer ribonucleic acid synthetase. Biochemistry. 1974;13(3):481-5.

[81] Bernatowicz MS, Matsueda GR. Preparation of peptide-protein immunogens using N-succinimidyl bromoacetate as a heterobifunctional crosslinking reagent. Anal Biochem. 1986;155(1):95-102.

[82] Davies ME, Knight CG, Mativi BY. Antibodies to a short synthetic peptide cross-react with human recombinant interleukin 1 alpha. Immunol Lett. 1988;19(4):293-7.

[83] Zaitsu K, Ohnishi M, Hosoya H, Sugimoto H, Ohkura Y. New heterobifunctional cross-linking reagents for protein conjugation, N-(bromoacetamido-n-alkanoyloxy)succinimides. Chem Pharm Bull (Tokyo). 1987;35(5):1991-7.

[84] Gershkovich A. A., Serebryanyy S. B. Synthesis and application of 2-nitro-4-sulphophenyl esters in peptide synthesis. IV Proc. symposium. in chemistry of proteins and peptides: Proc. of reports. - Minsk 1977:188.

[85] Gershkovich AA, Serebryany SB. Application of water-soluble 2-nitro-4-sulphophenyl esters in peptide synthesis. Bioorg Khim. 1978; 4(8):1129-31.

[86] Gershkovich AA, Serebryany SB. Water-soluble 2-nitro-4-sulphophenyl esters in peptide synthesis. Bioorg Khim. 1979; 5(8):1125-1132.

[87] Klausner YS, Meiri TH, Schneider E. Peptide synthesis in aqueous solution with o-nitro-p-sulfophenyl esters. 5-th Amer. Peptide Symp. : 1989 Proc. New York etc.: J. Welley and Sons. 623 p.

[88] Radavsky YuL, Gershkovich AA, Mogiryoua LA, et al. The use of 2-nitro-4-sulfophenyl esters immunochemical studies. V Proc. symposium. in chemistry and physics of proteins and peptides: Proc. of reports. Baku, 1980; 225.

[89] Radavsky YuL, Mogiryoua LA, Man'ko NI, Gershkovich AA. Use of water-soluble 2-nitro-4-sulfophenyl esters for synthesis of acid conjugates with proteins. Bioorg Khim. 1982; 8(11):1486-1489

[90] Luk'ianchuk VD, LuÄ­k AI, RadavskiÄ­ IuL, VoÄ­tenko NS, Gershkovich AA. Experimental specific immunotherapy of acute poisoning by dinitrophenol compounds. Vestn Akad Med Nauk SSSR. 1988;(5):38-42.

[91] Staros JV. N-hydroxysulfosuccinimide active esters: bis(N-hydroxysulfosuccinimide) esters of two dicarboxylic acids are hydrophilic, membrane-impermeant, protein cross-linkers. Biochemistry. 1982;21(17):3950-5.

[92] Gershkovich A.A, Radavsky YuL, Parteshko AV, Goncharenko VS. Bis- (2-nitro-4-sulphophenyl) esters of dicarboxylic acids as water-soluble bifunctional reagents for protein cross-linking. Bioorg Khim. 1989; 15 (8):1056-1059

[93] ZaÄ­tseva LS, Gershkovich AA, RadavskiÄ­ IuL, Abakumov VIu. Use of water-soluble 2-nitro-4-sulfophenyl ester of adipic acid for preparation of peptide protein conjugates. Ukr Biokhim Zh. 1992;64(3):101-3.

[94] Lindner W, Robey FA. Automated synthesis and use of N-chloroacetyl-modified peptides for the preparation of synthetic peptide polymers and peptide-protein immunogens. Int J Pept Protein Res. 1987;30(6):794-800.

[95] Robey FA, Fields RL. Automated synthesis of N-bromoacetyl-modified peptides for the preparation of synthetic peptide polymers, peptide-protein conjugates, and cyclic peptides. Anal Biochem. 1989;177(2):373-7.

[96] Jue R, Lambert JM, Pierce LR, Traut RR. Addition of sulfhydryl groups to Escherichia coli ribosomes by protein modification with 2-iminothiolane (methyl 4-mercaptobutyrimidate). Biochemistry. 1978;17(25):5399-406. PubMed PMID: 365229.

[97] Albericio F, Andreu D, Giralt E, Navalpotro C, Pedroso E, Ponsati B, Ruiz-Gayo M. Use of the Npys thiol protection in solid phase peptide synthesis. Application to direct peptide-protein conjugation through cysteine residues. Int J Pept Protein Res. 1989;34(2):124-8.

[98] Goddard P, McMurray JS, Sheppard RC, Emson P. A solubilisable polymer support suitable for solid phase peptide synthesis and for injection into experimental animals. J Chem Soc Chem Commun. 1988;(15):1025-7.

[99] Atherton E, Gait MJ, Sheppard RC, Williams BJ. The polyamide method of solid phase peptide and oligonucleotide synthesis. Bioorg Chem. 1979;8(3):351–70.

[100] Dryland A, Sheppard RC. Peptide synthesis. Part 8. A system for solid-phase synthesis under low pressure continuous flow conditions. J Chem Soc. (RSC); 1986;125-38.

[101] Hardy PM, Nicholls AC, Rydon HN. The nature of the cross-linking of proteins by glutaraldehyde. Part I. Interaction of glutaraldehyde with the amino-groups of 6-aminohexanoic acid and of alpha-N-acetyl-lysine. J Chem Soc Perkin 1. 1976;(9):958-62.

[102] Dietzen RG, Sander E, Christner J, Jung G. Examination of a new cross-linker in monoclonal antibody reaction against the Oterminus of Tobacco mosaic virus coat protein. Z Naturforsch. 1987; 266: 441-53.